rs6966525

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001277115.2(DNAH11):​c.188G>C​(p.Gly63Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000587 in 1,558,042 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.60

Publications

1 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0055802763).
BP6
Variant 7-21543433-G-C is Benign according to our data. Variant chr7-21543433-G-C is described in ClinVar as Benign. ClinVar VariationId is 257876.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00311 (474/152366) while in subpopulation AFR AF = 0.0108 (450/41602). AF 95% confidence interval is 0.00999. There are 3 homozygotes in GnomAd4. There are 222 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.188G>C p.Gly63Ala missense_variant Exon 1 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.188G>C p.Gly63Ala missense_variant Exon 1 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5
DNAH11ENST00000607050.1 linkn.-13G>C upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00307
AC:
468
AN:
152248
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0107
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000683
AC:
112
AN:
163904
AF XY:
0.000527
show subpopulations
Gnomad AFR exome
AF:
0.0110
Gnomad AMR exome
AF:
0.000476
Gnomad ASJ exome
AF:
0.000116
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000307
Gnomad OTH exome
AF:
0.000218
GnomAD4 exome
AF:
0.000314
AC:
441
AN:
1405676
Hom.:
1
Cov.:
35
AF XY:
0.000284
AC XY:
197
AN XY:
693908
show subpopulations
African (AFR)
AF:
0.0103
AC:
331
AN:
32084
American (AMR)
AF:
0.000746
AC:
27
AN:
36212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25252
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36498
South Asian (SAS)
AF:
0.0000125
AC:
1
AN:
79796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49652
Middle Eastern (MID)
AF:
0.000701
AC:
4
AN:
5708
European-Non Finnish (NFE)
AF:
0.0000305
AC:
33
AN:
1082192
Other (OTH)
AF:
0.000772
AC:
45
AN:
58282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00311
AC:
474
AN:
152366
Hom.:
3
Cov.:
33
AF XY:
0.00298
AC XY:
222
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.0108
AC:
450
AN:
41602
American (AMR)
AF:
0.000784
AC:
12
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68030
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000915
Hom.:
1
Bravo
AF:
0.00333
ESP6500AA
AF:
0.00915
AC:
35
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.000657
AC:
76
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 14, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
20
DANN
Benign
0.90
DEOGEN2
Benign
0.11
.;.;T
Eigen
Benign
0.065
Eigen_PC
Benign
0.076
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.72
T;T;T
MetaRNN
Benign
0.0056
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
.;.;L
PhyloP100
4.6
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.3
.;N;.
REVEL
Benign
0.11
Sift
Benign
0.60
.;T;.
Polyphen
0.95
.;.;P
Vest4
0.22
MVP
0.23
ClinPred
0.024
T
GERP RS
4.0
PromoterAI
0.0050
Neutral
Varity_R
0.24
gMVP
0.35
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6966525; hg19: chr7-21583051; API